Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson’s Disease Daphne RobakisStanley Fahn Current Opinion 12 July 2015 Pages: 433 - 441
Targeting CGRP: A New Era for Migraine Treatment Stephanie Wrobel GoldbergStephen David Silberstein Current Opinion 03 July 2015 Pages: 443 - 452
Developing Medications Targeting Glutamatergic Dysfunction in Autism: Progress to Date Lawrence K. FungAntonio Y. Hardan Leading Article 24 June 2015 Pages: 453 - 463
Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations Caroline A. AroutEllen EdensMehmet Sofuoglu Review Article 04 July 2015 Pages: 465 - 486
Alzheimer’s Disease: Lessons Learned from Amyloidocentric Clinical Trials Andreas SoejitnoAnastasia TjanThomas Eko Purwata Review Article 18 July 2015 Pages: 487 - 502
Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US Patients Barbara H. JohnsonMachaon M. BonafedeCrystal Watson Original Research Article Open access 26 June 2015 Pages: 503 - 510
Oxycodone/Naloxone PR: A Review in Severe Refractory Restless Legs Syndrome James E. Frampton Adis Drug Evaluation 02 July 2015 Pages: 511 - 518